![](/img/cover-not-exists.png)
Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na–K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?
Hashim Khan, Marco Metra, John E. A. Blair, Mark Vogel, Matthew E. Harinstein, Gerasimos S. Filippatos, Hani N. Sabbah, Herve Porchet, Giovanni Valentini, Mihai GheorghiadeVolume:
14
Language:
english
Pages:
11
DOI:
10.1007/s10741-009-9136-z
Date:
December, 2009
File:
PDF, 554 KB
english, 2009